IRCT201503173106N24已完成未知
Evaluation of TNFa Levels in Psoriatic Plaque Tissue after topical St Johns Wort (Hypericum perforatum L) Application in Patients with Plaque Type Psoriasis vulgaris
Islamic Azad University, Pharmaceutical Sciences Branch0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years(—)
- 性别
- All
入选标准
- •patients with the age between 18 to 50 years old; diagnosis of mild to moderate plaque type psoriasis on both sides of the body; not being under medical treatment for the past two months.
- •Exclusion criteria: pregnancy; lactation; suffering from a major illness (such as cardiovascular disease, acute renal or liver disease, cancer or active malignancy); not having plaque psoriasis on both sides of the body.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus InfectionPsoriasisInflammatory Bowel DiseasesNCT02376478Medical University of Vienna222
Unknown
2 期
99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes ActivityArthritisPsoriatic ArthritisNCT02134613Universidade Federal do Rio de Janeiro50
未知
3 期
ong-term study of TA-650 in patients with psoriasisPsoriasisJPRN-jRCT2080220314Mitsubishi Tanabe Pharma Corporation
进行中(未招募)
不适用
Determination of antipsoriatic efficacy of topical paroxetine hydrochloride ointments in a psoriasis plaque testhealthy subjectsEUCTR2004-004740-51-DEAgis Industries (1983) ltd.15
进行中(未招募)
不适用
Determination of antipsoriatic efficacy of topical formulations and comparison to a brand medication and placebo in a psoriasis plaque testMale or female subjects aged 18 to 64 are eligible for the study insofar that they suffer from chronic plaque type psoriasis.EUCTR2005-004859-35-DEG&W Laboratories, Inc.15
